We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
-3.99%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
–
AUM
$3.53B
AUM Growth
-$528M
Cap. Flow
-$324M
Cap. Flow %
-9.18%
Top 10 Hldgs %
29.69%
Holding
1,565
New
259
Increased
499
Reduced
543
Closed
256

Top Buys

Rank Stock Value
1
GBIL icon
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
+$365M
2
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$365M
3
EMR icon
Emerson Electric
EMR
+$25.8M
4
VDE icon
Vanguard Energy ETF
VDE
+$23.4M
5
UNH icon
UnitedHealth
UNH
+$15.7M

Top Sells

Rank Stock Value
1
BLV icon
Vanguard Long-Term Bond ETF
BLV
+$158M
2
USRT icon
iShares Core US REIT ETF
USRT
+$141M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$138M
4
VXF icon
Vanguard Extended Market ETF
VXF
+$101M
5
VGLT icon
Vanguard Long-Term Treasury ETF
VGLT
+$69.4M

Sector Composition

Rank Sector Weight
1 Technology 21.29%
2 Energy 11.87%
3 Healthcare 10.76%
4 Industrials 6.89%
5 Consumer Discretionary 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSTR icon
926
Landstar System
LSTR
$6.03B
$92.7K ﹤0.01%
524
-3,441
-87% -$661K
DAWN
927
DELISTED
Day One Biopharmaceuticals
DAWN
$92.2K ﹤0.01%
7,518
-2,895
-28% -$37.8K
EXAI
928
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$92K ﹤0.01%
20,359
+1,305
+7% +$8.43K
AMH icon
929
American Homes 4 Rent
AMH
$12.1B
$92K ﹤0.01%
2,730
+130
+5% +$4.67K
SWTX
930
DELISTED
SpringWorks Therapeutics
SWTX
$91.9K ﹤0.01%
3,973
-999
-20% -$27.3K
INBX
931
DELISTED
Inhibrx, Inc. Common Stock
INBX
$91.8K ﹤0.01%
5,005
-160
-3% -$3.35K
RCUS icon
932
Arcus Biosciences
RCUS
$3.33B
$91.3K ﹤0.01%
5,087
-1,888
-27% -$37.9K
RVMD icon
933
Revolution Medicines
RVMD
$38.5B
$91.2K ﹤0.01%
3,295
-2,262
-41% -$67.1K
ONC
934
BeOne Medicines Ltd
ONC
$33.9B
$91.2K ﹤0.01%
507
– –
LYEL icon
935
Lyell Immunopharma
LYEL
$318M
$91K ﹤0.01%
3,096
+909
+42% +$43.2K
IOVA icon
936
Iovance Biotherapeutics
IOVA
$2.04B
$90.3K ﹤0.01%
19,857
+3,777
+23% +$24.7K
AGEN
937
Agenus
AGEN
$276M
$90.3K ﹤0.01%
3,994
+368
+10% +$10.4K
RCL icon
938
Royal Caribbean
RCL
$86.8B
$89.7K ﹤0.01%
974
-20,640
-95% -$2.07M
ZNTL icon
939
Zentalis Pharmaceuticals
ZNTL
$332M
$89.7K ﹤0.01%
4,470
-1,184
-21% -$30.1K
SDGR icon
940
Schrodinger
SDGR
$1.13B
$89.6K ﹤0.01%
3,168
-321
-9% -$12.9K
RAPT
941
DELISTED
RAPT Therapeutics
RAPT
$89.2K ﹤0.01%
671
-154
-19% -$25.1K
USHY icon
942
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
$89.2K ﹤0.01%
+2,569
New +$90.3K
TECK icon
943
Teck Resources
TECK
$28.2B
$89.1K ﹤0.01%
2,067
-625
-23% -$25.9K
ELVN icon
944
Enliven Therapeutics
ELVN
$3.78B
$88.8K ﹤0.01%
6,500
-434
-6% -$7.31K
IPHA
945
Innate Pharma
IPHA
$171M
$88.5K ﹤0.01%
34,998
-7,433
-18% -$21.8K
SNDX icon
946
Syndax Pharmaceuticals
SNDX
$1.7B
$87.5K ﹤0.01%
6,028
-1,185
-16% -$22.4K
MOR
947
DELISTED
MorphoSys AG American Depositary Shares
MOR
$87.5K ﹤0.01%
13,016
-6,271
-33% -$48.3K
CMCSA icon
948
Comcast
CMCSA
$87.3B
$87K ﹤0.01%
1,963
-3,373
-63% -$151K
NGM
949
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$85.5K ﹤0.01%
79,882
+40,066
+101% +$82.9K
CRBU icon
950
Caribou Biosciences
CRBU
$146M
$85.4K ﹤0.01%
17,858
-11,210
-39% -$69.5K
36 37
38
39 40

Similar funds

DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
AM
AGF Management Toronto, Ontario, Canada $22.3B AUM 46.42% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Exchange Traded Concepts's Q3 2023 Portfolio in Review

As of Q3 2023, Exchange Traded Concepts held 1,565 positions worth $3.53B, down 13% from $4.06B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Exchange Traded Concepts withdrew a net $324M in Q3 2023, closing 256 positions and reducing 543 holdings. Its most notable exit was Vanguard Long-Term Bond ETF, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Exchange Traded Concepts opened a new position in Goldman Sachs Access Treasury 0-1 Year ETF worth $366M.

  • Exchange Traded Concepts's largest Q3 2023 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 3,652,937 shares worth $366M.
  • Exchange Traded Concepts added most to iShares 0-3 Month Treasury Bond ETF in Q3 2023, an estimated $365M increase.
  • Exchange Traded Concepts's biggest Q3 2023 reduction was National Instruments Corp, cutting an estimated $19.2M.
  • Exchange Traded Concepts fully exited Vanguard Long-Term Bond ETF in Q3 2023, selling an estimated $158M.
  • Exchange Traded Concepts's ten largest holdings make up 30% of its $3.53B portfolio in Q3 2023.
  • Exchange Traded Concepts opened 259 new positions and closed 256 in Q3 2023.
  • Exchange Traded Concepts's portfolio value fell 13% quarter-over-quarter to $3.53B.

Based on Exchange Traded Concepts's 13F filing for Q3 2023, filed 18 Oct 2023.